Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Magnetic resonance T2 mapping and diffusion-weighted imaging for early detection of cystogenesis and response to therapy in a mouse model of polycystic kidney disease.

Franke M, Baeßler B, Vechtel J, Dafinger C, Höhne M, Borgal L, Göbel H, Koerber F, Maintz D, Benzing T, Schermer B, Persigehl T.

Kidney Int. 2017 Dec;92(6):1544-1554. doi: 10.1016/j.kint.2017.05.024. Epub 2017 Jul 26.

PMID:
28754558
2.

T2 relaxation time and apparent diffusion coefficient for noninvasive assessment of renal pathology after acute kidney injury in mice: comparison with histopathology.

Hueper K, Rong S, Gutberlet M, Hartung D, Mengel M, Lu X, Haller H, Wacker F, Meier M, Gueler F.

Invest Radiol. 2013 Dec;48(12):834-42. doi: 10.1097/RLI.0b013e31829d0414.

PMID:
23907103
3.

Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injury.

Aihara M, Fujiki H, Mizuguchi H, Hattori K, Ohmoto K, Ishikawa M, Nagano K, Yamamura Y.

J Pharmacol Exp Ther. 2014 May;349(2):258-67. doi: 10.1124/jpet.114.213256. Epub 2014 Feb 25.

PMID:
24570071
4.

Ultrasound detection and characterization of polycystic kidney disease in a mouse model.

Pollard R, Yunis R, Kültz D, Martin P, Griffey S, Ferrara K.

Comp Med. 2006 Jun;56(3):215-21.

PMID:
16774131
5.

Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.

Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O.

Nature. 2006 Dec 14;444(7121):949-52. Epub 2006 Nov 22.

PMID:
17122773
6.
7.

Magnetic resonance imaging assessment of a murine model of recessive polycystic kidney disease.

Sun Y, Zhou J, Stayner C, Munasinghe J, Shen X, Beier DR, Albert MS.

Comp Med. 2002 Oct;52(5):433-8.

PMID:
12405636
8.

Characterization of soft tissue masses: can quantitative diffusion weighted imaging reliably distinguish cysts from solid masses?

Subhawong TK, Durand DJ, Thawait GK, Jacobs MA, Fayad LM.

Skeletal Radiol. 2013 Nov;42(11):1583-92. doi: 10.1007/s00256-013-1703-7. Epub 2013 Aug 24.

PMID:
23974467
9.

Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease.

Natoli TA, Husson H, Rogers KA, Smith LA, Wang B, Budman Y, Bukanov NO, Ledbetter SR, Klinger KW, Leonard JP, Ibraghimov-Beskrovnaya O.

Hum Mol Genet. 2012 Aug 1;21(15):3397-407. doi: 10.1093/hmg/dds172. Epub 2012 May 4.

10.

Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.

Smith LA, Bukanov NO, Husson H, Russo RJ, Barry TC, Taylor AL, Beier DR, Ibraghimov-Beskrovnaya O.

J Am Soc Nephrol. 2006 Oct;17(10):2821-31. Epub 2006 Aug 23.

11.

Polycystic kidney disease evaluation by magnetic resonance imaging in ischemia-reperfusion injured PKD1 knockout mouse model: comparison of T2-weighted FSE and true-FISP.

Zhou X, Bao H, Takakura A, Zhou J, Albert M, Sun Y.

Invest Radiol. 2010 Jan;45(1):24-8. doi: 10.1097/RLI.0b013e3181be3501.

PMID:
19996760
12.

Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures.

Natoli TA, Gareski TC, Dackowski WR, Smith L, Bukanov NO, Russo RJ, Husson H, Matthews D, Piepenhagen P, Ibraghimov-Beskrovnaya O.

Am J Physiol Renal Physiol. 2008 Jan;294(1):F73-83. Epub 2007 Oct 10.

13.

Diffusion-weighted MRI for early detection and characterization of prostate cancer in the transgenic adenocarcinoma of the mouse prostate model.

Hill DK, Kim E, Teruel JR, Jamin Y, Widerøe M, Søgaard CD, Størkersen Ø, Rodrigues DN, Heindl A, Yuan Y, Bathen TF, Moestue SA.

J Magn Reson Imaging. 2016 May;43(5):1207-17. doi: 10.1002/jmri.25087. Epub 2015 Nov 11.

PMID:
26559017
14.

Impact of measurement parameters on apparent diffusion coefficient quantification in diffusion-weighted-magnetic resonance imaging.

Schmidt H, Gatidis S, Schwenzer NF, Martirosian P.

Invest Radiol. 2015 Jan;50(1):46-56. doi: 10.1097/RLI.0000000000000095.

PMID:
25247326
15.

Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner.

Sadick M, Schock D, Kraenzlin B, Gretz N, Schoenberg SO, Michaely HJ.

Invest Radiol. 2009 Aug;44(8):469-75. doi: 10.1097/RLI.0b013e3181a8afa1.

PMID:
19465861
16.

Diffusion-weighted MR of the brain: methodology and clinical application.

Mascalchi M, Filippi M, Floris R, Fonda C, Gasparotti R, Villari N.

Radiol Med. 2005 Mar;109(3):155-97. Review. English, Italian.

PMID:
15775887
17.

4D MRI of polycystic kidneys from rapamycin-treated Glis3-deficient mice.

Xie L, Qi Y, Subashi E, Liao G, Miller-DeGraff L, Jetten AM, Johnson GA.

NMR Biomed. 2015 May;28(5):546-54. doi: 10.1002/nbm.3281. Epub 2015 Mar 23.

18.

Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease.

Liebau MC, Serra AL.

Pediatr Nephrol. 2013 Sep;28(9):1771-83. doi: 10.1007/s00467-012-2370-y. Epub 2012 Dec 14. Review.

PMID:
23239392
19.

Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis.

Husson H, Moreno S, Smith LA, Smith MM, Russo RJ, Pitstick R, Sergeev M, Ledbetter SR, Bukanov NO, Lane M, Zhang K, Billot K, Carlson G, Shah J, Meijer L, Beier DR, Ibraghimov-Beskrovnaya O.

Hum Mol Genet. 2016 Jun 1;25(11):2245-2255. Epub 2016 Apr 5.

20.

Efficacy of diffusion-weighted magnetic resonance imaging in detecting infected cysts in a case of polycystic kidney disease.

Katano K, Kakuchi Y, Nakashima A, Takahashi S, Kawano M.

Clin Nephrol. 2011 Feb;75 Suppl 1:24-6.

PMID:
21269589

Supplemental Content

Support Center